Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aidonio Fiolaki, Konstantinos I. Tsamis, Haralampos J. Milionis, Athanassios P. Kyritsis, Maria Kosmidou & Sotirios Giannopoulos. (2014) Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease. International Journal of Neuroscience 124:1, pages 1-11.
Read now
Read now
Articles from other publishers (12)
Larry B. Goldstein, Peter P. Toth, Jennifer L. Dearborn-Tomazos, Robert P. Giugliano, Benjamin J. Hirsh, Jessica M. Peña, Magdy H. Selim & Daniel Woo. (2023) Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology.
Crossref
Crossref
Ruth Peters, John Breitner, Sarah James, Gregory A. Jicha, Pierre‐Francois Meyer, Marcus Richards, A. David Smith, Hussein N. Yassine, Erin Abner, Atticus H. Hainsworth, Patrick G. Kehoe, Nigel Beckett, Christopher Weber, Craig Anderson, Kaarin J. Anstey & Hiroko H. Dodge. (2021) Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors. Alzheimer's & Dementia: Translational Research & Clinical Interventions 7:1.
Crossref
Crossref
Kun Xuan, Tianming Zhao, Guangbo Qu, Haixia Liu, Xin Chen & Yehuan Sun. (2020) The efficacy of statins in the treatment of Alzheimer’s disease: a meta-analysis of randomized controlled trial. Neurological Sciences 41:6, pages 1391-1404.
Crossref
Crossref
Marta Mejías-Trueba, María Antonia Pérez-Moreno & María Ángeles Fernández-Arche. (2018) Systematic review of the efficacy of statins for the treatment of Alzheimer’s disease. Clinical Medicine 18:1, pages 54-61.
Crossref
Crossref
Rania Hammami, Jihen Jdidi, Faten Triki, Bouthaina Hammami, Leila Abid, Kamilia Ksouda, Serria Hammami, Dorra Abid, Mourad Hentati & Samir Kammoun. (2016) Place des statines chez le sujet âgé. Thérapie.
Crossref
Crossref
Ramón Cacabelos, Clara Torrellas, Oscar Teijido & Juan Carlos Carril. (2016) Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics 17:9, pages 1041-1074.
Crossref
Crossref
Haopeng Xiao, Weixuan Chen, George X. Tang, Johanna M. Smeekens & Ronghu Wu. (2015) Systematic Investigation of Cellular Response and Pleiotropic Effects in Atorvastatin-Treated Liver Cells by MS-Based Proteomics. Journal of Proteome Research 14:3, pages 1600-1611.
Crossref
Crossref
S Zoungas, A J Curtis, J J McNeil & A M Tonkin. (2014) Treatment of Dyslipidemia and Cardiovascular Outcomes: The Journey So Far—Is This the End for Statins?. Clinical Pharmacology & Therapeutics 96:2, pages 192-205.
Crossref
Crossref
Bernadette McGuinness, David Craig, Roger Bullock, Reem Malouf & Peter Passmore. (2014) Statins for the treatment of dementia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Sophia Zoungas, Andrea Curtis, Andrew Tonkin & John McNeil. (2014) Statins in the elderly. Current Opinion in Cardiology 29:4, pages 372-380.
Crossref
Crossref
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado & Juan C. Carril. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
323
556
.
G.B. John Mancini, A. Yashar Tashakkor, Steven Baker, Jean Bergeron, David Fitchett, Jiri Frohlich, Jacques Genest, Milan Gupta, Robert A. Hegele, Dominic S. Ng, Glen J. Pearson & Janet Pope. (2013) Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update. Canadian Journal of Cardiology 29:12, pages 1553-1568.
Crossref
Crossref